Dlamini, PS, et al.
HIV stigma and missed medications in HIV-positive people in five African countries. AIDS patient care and STDs
2009; 23: 377–387.
Mazibuko, S. Decentralization of antiretroviral treatment in Swaziland: outcome of nurse initiated versus doctor initiated treatment: University of Pretoria, 2006.
van Schalkwyk, C, et al.
Outcomes and impact of HIV prevention, ART and TB programs in Swaziland–early evidence from public health triangulation. PLoS ONE
2013; 8: e69437.
UNAIDS. Swaziland country report on monitoring the political declaration on HIV and AIDS. 2012.
Miller, CM, et al.
Why are antiretroviral treatment patients lost to follow-up? A qualitative study from South Africa. Tropical Medicine & International Health
2010; 15: 48–54.
Fine, JP, Gray, RJ. A proportional hazards model for the subdistribution of a competing risk. Journal of the American Statistical Association
1999; 94: 496–509.
Molfino, L, et al.
High attrition among HIV-infected patients with advanced disease treated in an intermediary referral center in Maputo, Mozambique. Global Health Action
2013; 7: 23758.
Ditekemena, J, et al.
Antiretroviral treatment program retention among HIV-infected children in the Democratic Republic of Congo. PLoS ONE
2014; 9: e113877.
Braitstein, P, et al.
Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet
2006; 367: 817–824.
Auld, AF, et al.
Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy Programme. Pediatric Infectious Disease Journal
2014; 33: 1134–1140.
Centers for Disease Control and Prevention. Differences between HIV-infected men and women in antiretroviral therapy outcomes-six African countries, 2004–2012. Morbidity and Mortality Weekly Report
2013; 62: 945.
Boulle, A, et al.
Seven-year experience of a primary care antiretroviral treatment programme in Khayelitsha, South Africa. AIDS
2010; 24: 563–72.
Nash, D, et al.
Long-term immunologic response to antiretroviral therapy in low-income countries: collaborative analysis of prospective studies: The Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration of the International epidemiological Databases to Evaluate AIDS. AIDS (London, England)
2008; 22: 2291.
Scholten, F, et al.
Health and functional status among older people with HIV/AIDS in Uganda. BMC Public Health
2011; 11: 1.
Koole, O, et al.
Retention in a NGO supported antiretroviral program in the Democratic Republic of Congo. PLoS ONE
2012; 7: e40971.
Mutasa-Apollo, T, et al.
Patient retention, clinical outcomes and attrition-associated factors of HIV-infected patients enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007–2010. PLoS ONE
2014; 9: e86305.
Decroo, T, et al.
Lessons learned during down referral of antiretroviral treatment in Tete, Mozambique. Journal of the International AIDS Society
2009; 12: 6.
Fatti, G, Grimwood, A, Bock, P. Better antiretroviral therapy outcomes at primary healthcare facilities: an evaluation of three tiers of ART services in four South African provinces. PLoS ONE
2010; 5: e12888.
Rueda, S, et al.
Patient support and education for promoting adherence to highly active antiretroviral therapy for HIV/AIDS. Cochrane Database of Systematic Reviews
2006; 3 (3).
Sulzbach, S, Wang, W, Ohanlon, B. Assessing the role of the private health sector in HIV/AIDS service delivery in Ethiopia, 2009.
Ekstrand, ML, et al.
Suboptimal adherence associated with virological failure and resistance mutations to first-line highly active antiretroviral therapy (HAART) in Bangalore, India. International Health
2011; 3: 27–34.